Selected article for: "high dose and low dose"

Author: Lan, Jiaming; Yao, Yanfeng; Deng, Yao; Chen, Hong; Lu, Guangwen; Wang, Wen; Bao, Linlin; Deng, Wei; Wei, Qiang; Gao, George F.; Qin, Chuan; Tan, Wenjie
Title: Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge()
  • Document date: 2015_8_18
  • ID: q8i2gfut_31
    Snippet: To assess the humoral immune response to the rRBD vaccine in rhesus macaques, total anti-MERS-CoV RBD IgG antibody titres were determined by ELISA. Low titres of IgG in serum samples before prime vaccination were detected, possibly due to non-specific responses. IgG titres in the high-dose group increased significantly (p b 0.05) after the first vaccination (Fig. 2a) , and achieved the highest titre of RBDspecific IgG 2 weeks after the second imm.....
    Document: To assess the humoral immune response to the rRBD vaccine in rhesus macaques, total anti-MERS-CoV RBD IgG antibody titres were determined by ELISA. Low titres of IgG in serum samples before prime vaccination were detected, possibly due to non-specific responses. IgG titres in the high-dose group increased significantly (p b 0.05) after the first vaccination (Fig. 2a) , and achieved the highest titre of RBDspecific IgG 2 weeks after the second immunisation. Sera IgG titre in the low-dose group increased (p b 0.05) only after the second immunisation, to almost the same level as that of the high-dose group. RBD-specific IgG in the sera of immunised rhesus macaques was preserved for at least 17 weeks without obvious decline. In addition, IgG titre increased rapidly after a subsequent boost. Increased IgG titre was particularly marked in the low-dose group.

    Search related documents:
    Co phrase search for related documents
    • immune response and low titre: 1, 2
    • immune response and non specific response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • immune response and prime vaccination: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and rapidly increase: 1, 2, 3, 4, 5
    • immune response and rhesus macaque: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • immune response and rrbd vaccine: 1, 2
    • immune response and second immunisation: 1
    • immune response and serum sample: 1, 2, 3, 4
    • immune response and significantly increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • immune response and subsequent boost: 1, 2
    • low dose and prime vaccination: 1, 2, 3
    • low dose and rhesus macaque: 1, 2, 3, 4
    • low dose and rhesus macaque rrbd vaccine: 1
    • low dose and rrbd vaccine: 1, 2, 3
    • low dose and second immunisation: 1, 2
    • low dose and significantly increase: 1, 2, 3, 4, 5, 6, 7, 8
    • low dose and subsequent boost: 1, 2
    • low dose group and prime vaccination: 1
    • low dose group and second immunisation: 1